Thomas F Luscher
Overview
Explore the profile of Thomas F Luscher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
1145
Citations
22055
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Chen C, Sawamura T, Akhmedov A, Tsai M, Akyol O, Kakino A, et al.
Eur J Clin Invest
. 2025 Mar;
:e70019.
PMID: 40045739
Background: Low-density lipoprotein (LDL) is a central player in atherogenesis and has long been referred to as 'bad cholesterol.' However, emerging evidence indicates that LDL functions in multifaceted ways beyond...
3.
Windecker S, Fraser A, Szymanski P, Gilard M, Luscher T, Abid L, et al.
Eur Heart J
. 2025 Feb;
PMID: 39977258
The European Union (EU) Medical Device Regulation increased regulatory scrutiny to improve the safety and performance of new medical devices. An equally important goal is providing timely access to innovative...
4.
Liberale L, Tual-Chalot S, Sedej S, Ministrini S, Georgiopoulos G, Grunewald M, et al.
Nat Rev Cardiol
. 2025 Feb;
PMID: 39972009
Ageing of the cardiovascular system is associated with frailty and various life-threatening diseases. As global populations grow older, age-related conditions increasingly determine healthspan and lifespan. The circulatory system not only...
5.
6.
Muller M, Brand A, Mattig I, Spethmann S, Messroghli D, Hahn K, et al.
Circ Heart Fail
. 2025 Jan;
18(2):e012146.
PMID: 39866106
Background: Despite previous histopathologic evidence for its presence, the role of myocardial inflammation in the development and progression of cardiac transthyretin amyloidosis (ATTR-CA) remains insufficiently understood. Thus, this study sought...
7.
Galusko V, Wenzl F, Vandenbriele C, Panoulas V, Luscher T, Gorog D
Eur J Heart Fail
. 2025 Jan;
PMID: 39822053
Cardiogenic shock (CS) carries a 30-50% in-hospital mortality rate, with little improvement in outcomes in the last decade. Challenges in improving outcomes are closely linked to the frequent late presentation...
8.
Luscher T
Eur Heart J Cardiovasc Pharmacother
. 2025 Jan;
11(2):109-111.
PMID: 39805730
No abstract available.
9.
10.
Luscher T, Deanfield J
Int J Cardiol Congenit Heart Dis
. 2024 Dec;
14:100480.
PMID: 39712982
No abstract available.